CCL2 and neoplasm: The murine model of liver cancer indicated that FAP+ cancer-associated fibroblasts (CAFs) are the main source of chemokine (C-C motif) ligand 2 (CCL2), and fibroblast STAT3-CCL2 signaling inhibited tumor growth through enhanced recruitment of myeloid-derived suppressor cells.